NeuroQuant Dementia

Age Related Atrophy Report

For the assessment of dementia, Alzheimer’s disease and other neurodegenerative conditions

The NeuroQuant Dementia report helps physicians in the assessment of patients with cognitive impairment and memory loss, providing objective quantitative measurements of neurodegeneration of the hippocampus and inferior lateral ventricles, which is especially helpful in the evaluation of neurodementias.

Schedule a Demo

Discover the Benefits of NeuroQuant

See how quantitative imaging fits easily into your workflow

Start a conversation
Benefits and Features

How will NeuroQuant Improve Your MRI Assessment?

Quantify Information

Support your clinical impression with objective, volumetric data and color-coded images of brain structures.

Save Time

Automatic image segmentation from radiographic images (3D T1 MRI) is available in PACS in 5-7 minutes.

Track Progression Over Time

Longitudinal reporting enables physicians to monitor structure volumes and visually evaluate changes with color-coded overlays and change quantification data when prior scan data is available—all indicated on the same report.

Diagnose & Plan Earlier

Identify and assess neurodegeneration in its earliest stages to aid in treatment and lifestyle planning for patients.

Normative Reference Data

Normative reference data, based on the Cortechs.ai normative database, empowers NeuroQuant to provide comparisons of an individual’s brain structure volume measurements to a normal population.

Accuracy Across All Ages

Cortechs.ai’s Dynamic Atlas™ technology has been validated over thousands of clinical cases, allowing for segmentation of ages 3-100.